The adoption of servitization strategies by UK-based manufacturers

Almost all manufacturers offer services, but some use these as the basis for their competitive strategy. This is a growing area of interest among practitioners, policy makers, and academics, yet little is known about the adoption of servitization by UK manufacturers. In this paper a survey is presented that has been used to explore the extent, motivations, challenges, and successes of servitization within the business-to-business sector. The findings indicate, for example, that many manufacturers are succeeding with their service strategies, that they are attracted to these as a source of customer focus and revenue growth, and that such strategies require less organizational change than might be expected. Although the findings from the survey should be treated as preliminary, and further work is needed to confirm their reliability and insight, they indicate that servitization is proving to be a powerful competitive weapon for many companies

Multi-factor service design: identification and consideration of multiple factors of the service in its design process

Service design is a multidisciplinary area that helps innovate services by bringing new ideas to customers through a design-thinking approach. Services are affected by multiple factors, which should be considered in designing services. In this paper, we propose the multi-factor service design (MFSD) method, which helps consider the multi-factor nature of service in the service design process. The MFSD method has been developed through and used in five service design studies with industry and government. The method addresses the multi-factor nature of service for systematic service design by providing the following guidelines: (1) identify key factors that affect the customer value creation of the service in question (in short, value creation factors), (2) define the design space of the service based on the value creation factors, and (3) design services and represent them based on the factors. We provide real stories and examples from the five service design studies to illustrate the MFSD method and demonstrate its utility. This study will contribute to the design of modern complex services that are affected by varied factors

Robenidine treatment of rabbits naturally infected with coccidia.

&lt;p&gt;New Zealand White rabbits naturally infected with Eimeria intestinalis, E. magna, E. media and E. perforans and fed 100 parts/10(6) robenidine in their diet for 70 days ceased to excrete oocysts in their faeces after 19 days of treatment.&lt;/p&gt;</p

Field trial with the coccidiostatics metichlorpindol and robenidine in a rabbit farm.

&lt;p&gt;The effect of metichlorpindol and robenidine in broiler rabbits was examined. Administration of 125 ppm metichlorpindol did not reduce mortality and oocyst output significantly. In comparison with unmedicated rabbits, weight gain of metichlorpindol medicated rabbits was 4.76% lower after seven seeks of treatment, whereas feed conversion was improved by 1.87%. There was no effect on the production index. Medication with 33 and 66 ppm robenidine resulted in a significant reduction of mortality and oocyst output (0.05 &gt; P &gt; 0.01). The effect on oocyst reduction became already significant after two weeks of treatment. After four weeks both robenidine medicated groups gained significantly (0.05 &gt; P &gt; 0.01) more weight than metichlorpindol medicated and non medicated rabbits. After seven weeks of medication only the 66 ppm medicated group gained significantly (0.05 &gt; P &gt; 0.01) more weight than the 125 ppm metichlorpindol medicated group. In comparison with non medicated rabbits weight gain was 3.46% better. Feed conversion was improved by 6.76 and 6.55% at 33 and 66 ppm levels respectively, while the production index was improved by 19% and 22% respectively in comparison with non medicated and metichlorpindol medicated rabbits.&lt;/p&gt;</p

Evolution of coccidial infection in commercial and domestic rabbits between 1982 and 1986.

&lt;p&gt;Caecal samples were collected from 751 domestic rabbits of various origin and from 1229 diarrhoeic rabbits issued from 61 commercial rabbitries. They were screened for coccidiosis. In 1982, the year of introduction of the anticoccidial robenidine in commercial rabbit feeds, a dramatic decrease of coccidial infection ratio was detected in commercial rabbitries: only 6% of samples contained greater than 100 oocysts per gram against 85% in 1979, when sulphaquinoxaline/pyrimethamine was used. Only Eimeria magna, E. media and E. perforans were detected, whereas the highly pathogenic species E. flavescens and E. intestinalis had disappeared from commercial units. After 4 years of continuous use of robenidine, infection ratio rose progressively, although still far below the 1979 levels. Most of the other species reappeared, but only in very low proportions (1-4% of samples). The percentage occurrence of E. magna, E. media and E. perforans on the contrary rose progressively to 25, 26 and 34%, respectively, suggesting drug resistance. In domestic rabbitries, the incidence of coccidial infection was markedly higher and all nine species of Eimeria were detected. Eimeria magna, E. media and E. perforans were very common, E. flavescens, E. intestinalis, E. piriformis and E. stiedai were less common, whereas E. irresidua and E. coecicola were relatively rare. Notwithstanding the lower activity of robenidine against E. stiedai, no rise of hepatic coccidiosis became evident.&lt;/p&gt;</p